Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CervoMed Inc shares valued at $18,160 were purchased by ELDER WILLIAM ROBERT on Aug 27 ’24. At $18.16 per share, ELDER WILLIAM ROBERT acquired 1,000 shares. The insider’s holdings grew to 1,267 shares worth approximately $2762.0600000000004 following the completion of this transaction.
As published in a research note from H.C. Wainwright on December 17, 2024, CervoMed Inc [CRVO] has been rated down from a Buy to a Neutral. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Underweight”‘ outlook in a report released in mid December. As of December 11, 2024, Chardan Capital Markets has decreased its “Buy” rating to a “Neutral” for CRVO. Earlier on December 10, 2024, D. Boral Capital downgraded its rating. Their new recommendation was “a Hold” for CRVO stock which previously was a “a Buy”.
Analyzing CRVO Stock Performance
During the last five days, there has been a drop of approximately -6.84%. Over the course of the year, CervoMed Inc shares have dropped approximately -6.84%. Shares of the company reached a 52-week high of $2.43 on 01/07/25 and a 52-week low of $2.16 on 01/08/25. A 50-day SMA is recorded $7.57, while a 200-day SMA reached $15.44. Nevertheless, trading volume fell to 0.14 million shares from 0.27 million shares the previous day.
Support And Resistance Levels for CervoMed Inc (CRVO)
According to the 24-hour chart, there is a support level at 2.13, which, if violated, would cause prices to drop to 2.07. In the upper region, resistance lies at 2.27. The next price resistance is at 2.35. RSI (Relative Strength Index) is 27.72 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.00, which suggests the price will decrease in the coming days. Percent R is at 51.56%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
